X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (925) 925
Book Review (269) 269
Publication (94) 94
Newsletter (44) 44
Book Chapter (10) 10
Newspaper Article (6) 6
Book / eBook (4) 4
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (727) 727
humans (609) 609
male (544) 544
prostate cancer (491) 491
antiandrogens (461) 461
antiandrogen (288) 288
oncology (261) 261
prostatic neoplasms - drug therapy (248) 248
cancer (232) 232
animals (226) 226
androgens (213) 213
androgen receptor (209) 209
androgen antagonists - therapeutic use (187) 187
receptors, androgen - metabolism (171) 171
care and treatment (169) 169
urology & nephrology (169) 169
prostatic neoplasms - pathology (154) 154
research (144) 144
prostate (141) 141
cell line, tumor (136) 136
castration (133) 133
enzalutamide (130) 130
receptors, androgen - genetics (120) 120
analysis (118) 118
female (116) 116
endocrinology & metabolism (110) 110
chemotherapy (109) 109
health aspects (108) 108
testosterone (108) 108
prostatic neoplasms - metabolism (106) 106
therapy (103) 103
abiraterone (102) 102
metastasis (101) 101
aged (100) 100
phenylthiohydantoin - analogs & derivatives (98) 98
antiandrogen withdrawal (94) 94
mice (91) 91
pharmacology & pharmacy (91) 91
prostatic neoplasms, castration-resistant - drug therapy (89) 89
drug therapy (86) 86
expression (86) 86
middle aged (86) 86
treatment outcome (86) 86
progression (85) 85
antineoplastic agents, hormonal - therapeutic use (84) 84
ketoconazole (84) 84
abiraterone acetate (80) 80
androgen antagonists - pharmacology (80) 80
mutation (76) 76
docetaxel (75) 75
increased survival (74) 74
tumors (74) 74
prostatic neoplasms - genetics (73) 73
antineoplastic agents - therapeutic use (72) 72
spironolactone (71) 71
resistance (70) 70
article (69) 69
drug resistance, neoplasm (69) 69
bicalutamide (68) 68
cells (68) 68
development and progression (68) 68
physiological aspects (67) 67
orchiectomy (66) 66
gene expression (64) 64
flutamide (63) 63
medicine & public health (63) 63
urology (63) 63
abridged index medicus (62) 62
castration-resistant prostate cancer (62) 62
cell biology (62) 62
antineoplastic agents - pharmacology (61) 61
carcinoma (61) 61
growth (61) 61
antitumor-activity (59) 59
disease progression (58) 58
survival (58) 58
cell proliferation - drug effects (57) 57
prostate-specific antigen - blood (57) 57
biochemistry & molecular biology (56) 56
phenylthiohydantoin - therapeutic use (56) 56
signal transduction (54) 54
adult (53) 53
aged, 80 and over (53) 53
antiandrogen resistance (53) 53
drug resistance (53) 53
prostatic neoplasms, castration-resistant - pathology (53) 53
ligands (52) 52
urologic and male genital diseases (51) 51
apoptosis (50) 50
cancer therapies (50) 50
genetic aspects (50) 50
androgen receptor antagonists - pharmacology (49) 49
inhibition (48) 48
prostate-cancer (48) 48
proteins (48) 48
rats (48) 48
drugs (47) 47
hormones (47) 47
oncology, experimental (47) 47
androgen antagonists - adverse effects (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (960) 960
French (15) 15
German (10) 10
Spanish (4) 4
Russian (2) 2
Portuguese (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 10/2017, Volume 16, Issue 10, pp. 2281 - 2291
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, pp. e19059 - e19059
Background: Constitutively active androgen receptor variants (AR-V) lacking the ligand binding domain (LBD) may promote the development of castration-resistant... 
ACTIVATION | ANTIANDROGEN | MECHANISM | APOPTOTIC CELL-DEATH | GROWTH | MUTATION | BIOLOGY | THERAPY RESISTANCE | INHIBITOR ABIRATERONE ACETATE | ANTITUMOR-ACTIVITY | PROGRESSION | Cell Cycle - genetics | Prognosis | Humans | Middle Aged | Receptors, Androgen - metabolism | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Male | Gene Expression Profiling | RNA, Messenger - metabolism | Bone Neoplasms - pathology | Prostate - metabolism | Prostate - pathology | Cell Nucleus - metabolism | Protein Isoforms - metabolism | Protein Isoforms - chemistry | Aged, 80 and over | Receptors, Androgen - chemistry | Bone Neoplasms - genetics | Protein Structure, Tertiary | Prostatic Neoplasms - pathology | Bone Neoplasms - diagnosis | Prostatic Neoplasms - surgery | RNA, Messenger - genetics | Orchiectomy | Receptors, Androgen - genetics | Prostate - cytology | Survival Analysis | Ligands | Aged | Protein Isoforms - genetics | Proteins | Immunohistochemistry | Androgens | Messenger RNA | Analysis | Genomics | Genomes | Genetic aspects | Genetic transcription | Metastasis | Hormones | Prostate cancer | Drugs | Alternative splicing | Transcription | Genes | Bone tumors | Bone surgery | Cancer therapies | Urology | Western blotting | Metastases | Cell growth | Castration | Surgery | Cell cycle | Cell survival | Gene expression | Patients | Survival | Polymerase chain reaction | Pathology | Protein arrays | Bone cancer | Orthopedics | Bone | Prostate | Tumors | Cancer | Apoptosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2018, Volume 8, Issue 4, pp. 444 - 457
Primary resistance to androgen receptor (AR)-directed therapies in metastatic castration-resistant prostate cancer (mCRPC) is poorly understood. We randomized... 
SUPPRESS | EVOLUTION | ANTIANDROGEN | VARIANTS | BIOMARKER | AR-V7 | ONCOLOGY | LINEAGE PLASTICITY | EXPRESSION | CELL-FREE DNA | BLOOD | Index Medicus
Journal Article
Current Drug Targets, ISSN 1389-4501, 2018, Volume 19, Issue 6, pp. 613 - 620
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 18, pp. 3821 - 3830
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 02/2019, Volume 26, Issue 2, pp. 251 - 264
The role of androgen receptor (AR) in endocrine-resistant breast cancer is controversial and clinical trials targeting AR with an AR antagonist (e.g.,... 
breast cancer | endocrine resistance | PDX | enzalutamide | PROSTATE | TRANSCRIPTION | CELL-PROLIFERATION | ER-ALPHA | ANDROGEN RECEPTOR EXPRESSION | THERAPY | ANTIANDROGEN | ONCOLOGY | GROWTH | ENDOCRINOLOGY & METABOLISM | INHIBITOR | ACETATE
Journal Article
Oncotarget, ISSN 1949-2553, 12/2018, Volume 9, Issue 99, pp. 37284 - 37285
Journal Article
Oncotarget, 12/2018, Volume 9, Issue 99, pp. 37284 - 37285
Journal Article
Hormones and Cancer, ISSN 1868-8497, 4/2014, Volume 5, Issue 2, pp. 72 - 89
Despite new treatments for castrate-resistant prostate cancer (CRPC), the prognosis of patients with CRPC remains bleak due to acquired resistance to androgen... 
Medicine & Public Health | Microbiology | Oncology | Internal Medicine | Systems Biology | Endocrinology | Cell Biology | BREAST-CANCER | CARCINOMA-CELLS | SURVIVAL | ACTIVATION | ANTIANDROGEN | ONCOLOGY | GROWTH | ENDOCRINOLOGY & METABOLISM | CASTRATION | EXPRESSION | MIFEPRISTONE | ENZALUTAMIDE | Receptors, Glucocorticoid - antagonists & inhibitors | Humans | Receptors, Androgen - metabolism | Cell Survival - genetics | Drug Resistance, Neoplasm | Immunoblotting | Male | Receptors, Glucocorticoid - metabolism | Androgen Receptor Antagonists - pharmacology | Immediate-Early Proteins - metabolism | Dexamethasone - pharmacology | Prostatic Neoplasms - genetics | RNA Interference | HEK293 Cells | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Metribolone - pharmacology | Prostatic Neoplasms - drug therapy | Protein-Serine-Threonine Kinases - metabolism | Mifepristone - administration & dosage | Phenylthiohydantoin - pharmacology | Cell Survival - drug effects | Prostatic Neoplasms - pathology | Dexamethasone - administration & dosage | Protein-Serine-Threonine Kinases - genetics | Androgen Receptor Antagonists - administration & dosage | Metribolone - administration & dosage | Reverse Transcriptase Polymerase Chain Reaction | Phenylthiohydantoin - analogs & derivatives | Xenograft Model Antitumor Assays | Phenylthiohydantoin - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Immediate-Early Proteins - genetics | Receptors, Androgen - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Receptors, Glucocorticoid - genetics | Benzoates - pharmacology | Cell Line, Tumor | Mice | Mifepristone - pharmacology | Immediate-Early Proteins - antagonists & inhibitors | Microscopy, Fluorescence | Hormone receptors | Androgens | Care and treatment | Corticosteroids | Prognosis | Prostate-specific antigen | Physiological aspects | Genetic aspects | Research | Prostate cancer | Index Medicus
Journal Article